Home
Features
StockReports™
Analyse your stocks in seconds
Stock Research
Expert insight you can understand
StockRanks™
Identify winning stocks
Screeners
Generate investing ideas fast
Portfolios
Monitor and improve your performance
Charts and tools
Time your trades better
Education
Academy
All topics
Analyse stocks
Discover stocks
Investment strategy
Portfolio management
Additional resources
Events
Product guides
Ratio glossary
Newsletter
Reviews
Pricing
About
Menu
Get started
Log in
Sectors
Healthcare
Biotechnology & Medical Research
WuXi Biologics (Cayman)
2269 —
WuXi Biologics (Cayman)
Share News
HK$22.80
0.00
0.00%
Last trade -
00:00
Healthcare
Highly Speculative
Large Cap
High Flyer
Market Cap
HK$93.97bn
Enterprise Value
HK$91.72bn
Revenue
CNY18.68bn
Quality
78
Value
28
Momentum
99
Stock
Rank
™
80
StockReport™
Accounts
Balance sheet
Income statement
Cashflow statement
Dividend summary
News
2269 Dividends
StockReport™
Balance sheet
Income statement
Cashflow
News
2269 Dividends
RCS - Cydar Ltd - Kenneth Hitchner appointed Cydar Medical Chairman
14/02/2023 08:15
Announcement
REG - JPMorgan Inv. Trusts - Ten Largest Investments
16/09/2022 17:00
Announcement
Last trade - 00:00Last trade - 00:00Last trade - 00:00